Page 13 - Linical Evolution News Today

The two companies will combine tools to ‘accelerate’ and ‘de-risk’ the drug development process.

Since 1978, the US Food and Drink Administration has had in place the guidance for good laboratory practices (GLP) regulations.

Galapagos NV has announced it has initiated a phase 3 study with small molecule drug filgotinib in patients with the chronic, highly inflammatory condition, active axial spondyloarthritis(AxSpA).

Chiesi partners with BioLabs to gain access to certain sites and work with the companies using the facilities to advance rare disease research.

Since 1978, the US Food and Drink Administration has had in place the guidance for good laboratory practices (GLP) regulations.

The company announces plans to reorganize its business to focus on design-and-deployment engagements for on-site implementation of automated cloud labs.

The French company announces the opening of its facility, and the hiring of research scientists and formulation specialists that will staff the site.

Aerona Clinical is a medium sized pharmaceutical company, represented not only in the United Kingdom, but in Europe, and with a global reach. The company has been operating in this environment in the pharma industry for 15 to 20 years.

The German and Spanish companies use their relevant expertise in conjunction to provide clients with services spanning from hit generation to pre-clinical development.

A drug to treat a rare cancer that grows where the esophagus and stomach join has been accepted for review by the China National Medical Products Administration (NMPA).